187 related articles for article (PubMed ID: 7094510)
1. Plasma binding variations of amitriptyline and nortriptyline.
Pike E; Skuterud B
Clin Pharmacol Ther; 1982 Aug; 32(2):228-34. PubMed ID: 7094510
[TBL] [Abstract][Full Text] [Related]
2. The contribution of alpha 1-acid glycoprotein, lipoproteins, and albumin to the plasma binding of perazine, amitriptyline, and nortriptyline in healthy man.
Brinkschulte M; Breyer-Pfaff U
Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):61-6. PubMed ID: 6108517
[TBL] [Abstract][Full Text] [Related]
3. Interindividual differences in the binding of antidepressives to plasma proteins: the role of the variants of alpha 1-acid glycoprotein.
Tinguely D; Baumann P; Conti M; Jonzier-Perey M; Schöpf J
Eur J Clin Pharmacol; 1985; 27(6):661-6. PubMed ID: 3987771
[TBL] [Abstract][Full Text] [Related]
4. Significance of lipoproteins in serum binding variations of amitriptyline, nortriptyline, and quinidine.
Pike E; Skuterud B; Kierulf P; Lunde PK
Clin Pharmacol Ther; 1982 Nov; 32(5):599-606. PubMed ID: 7128000
[TBL] [Abstract][Full Text] [Related]
5. Distribution of amitriptyline and nortriptyline in blood: role of alpha-1-glycoprotein.
Amitai Y; Kennedy EJ; DeSandre P; Frischer H
Ther Drug Monit; 1993 Aug; 15(4):267-73. PubMed ID: 8236360
[TBL] [Abstract][Full Text] [Related]
6. Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline plasma levels.
Breyer-Pfaff U; Gaertner HJ; Kreuter F; Scharek G; Brinkschulte M; Wiatr R
Psychopharmacology (Berl); 1982; 76(3):240-4. PubMed ID: 6808544
[TBL] [Abstract][Full Text] [Related]
7. Clinical response and plasma concentrations of amitriptyline and its metabolite-nortriptyline in depressive patients.
Miljković B; Pokrajac M; Timotijević I; Varagić V
Eur J Drug Metab Pharmacokinet; 1996; 21(3):251-5. PubMed ID: 8980924
[TBL] [Abstract][Full Text] [Related]
8. A sensitive gas chromatographic assay for amitriptyline and nortriptyline in plasma.
Hals PA; Lundgren TI; Aarbakke J
Ther Drug Monit; 1982; 4(4):365-9. PubMed ID: 7157460
[TBL] [Abstract][Full Text] [Related]
9. Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels.
Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
Pharmacopsychiatry; 2003 Jul; 36(4):134-42. PubMed ID: 12905099
[TBL] [Abstract][Full Text] [Related]
10. Amitriptyline and nortriptyline plasma levels, urinary 3-methoxy-4-hydroxyphenylglycol and clinical response in depressed women.
Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Comincioli V; Zerbi F; Fenoglio L; Savoldi F
Neuropsychobiology; 1986; 16(2-3):97-102. PubMed ID: 3587582
[TBL] [Abstract][Full Text] [Related]
11. Binding of amitriptyline and nortriptyline in plasma determined from their equilibrium distributions between red cells and plasma, and between red cells and buffer solution.
Burch JE; Roberts SG; Raddats MA
Psychopharmacology (Berl); 1981; 75(3):262-72. PubMed ID: 6798617
[TBL] [Abstract][Full Text] [Related]
12. Specific radioimmunoassay for amitriptyline and nortriptyline in plasma.
Lucek R; Dixon R
Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):125-36. PubMed ID: 905625
[TBL] [Abstract][Full Text] [Related]
13. Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline.
Vandel S; Vandel B; Sandoz M; Allers G; Bechtel P; Volmat R
Eur J Clin Pharmacol; 1978 Nov; 14(3):185-90. PubMed ID: 365538
[TBL] [Abstract][Full Text] [Related]
14. Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.
Vandel S; Bertschy G; Jounet JM; Allers G
Ther Drug Monit; 1988; 10(4):386-9. PubMed ID: 3144066
[TBL] [Abstract][Full Text] [Related]
15. The demethylation of amitriptyline: a cross-over study of steady-state plasma levels of amitriptyline and nortriptyline in depressed patients.
Burch JE
Psychopharmacology (Berl); 1983; 80(3):254-8. PubMed ID: 6412270
[TBL] [Abstract][Full Text] [Related]
16. Distribution of nortriptyline in human blood: effects of temperature, pH, and drug concentration.
Slørdal L; Lundgren TI; Bessesen A; Sager G
Ther Drug Monit; 1987; 9(1):67-71. PubMed ID: 3576662
[TBL] [Abstract][Full Text] [Related]
17. Amitriptyline pharmacokinetics and clinical response: I. Free and total plasma amitriptyline and nortriptyline.
Baumann P; Jonzier-Perey M; Koeb L; Lê PK; Tinguely D; Schöpf J
Int Clin Psychopharmacol; 1986 Apr; 1(2):89-101. PubMed ID: 3571944
[TBL] [Abstract][Full Text] [Related]
18. Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression.
Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Zerbi F; Savoldi F
Psychopharmacology (Berl); 1990; 100(3):334-8. PubMed ID: 2315430
[TBL] [Abstract][Full Text] [Related]
19. A radioimmunoassay for the determination of combined amitriptyline and nortriptyline concentrations in microliter samples of plasma.
Robinson JD; Risby D; Riley G; Aherne GW
J Pharmacol Exp Ther; 1978 May; 205(2):499-502. PubMed ID: 641845
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of amitriptyline and its principal metabolite, nortriptyline, by GLC-chemical ionization mass spectrometry.
Garland WA
J Pharm Sci; 1977 Jan; 66(1):77-81. PubMed ID: 833746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
